|
|
Research
Overview
Our
lab is interested in the basic mechanisms that regulate growth,
the process whereby cells accumulate mass and increase in size.
Growth is a critical determinant of the sizes of cells, organs and
organisms and is often deranged in human diseases, such as diabetes
and cancer. In contrast to cell cycle progression, the mechanisms
that control growth are relatively poorly understood. Our long-term
goals are to identify and characterize these mechanisms and to understand
their roles in the normal and diseased physiology of mammals. Our
current focus is on a cellular system called the Target of Rapamycin
(TOR) pathway, a major regulator of growth in many eukaryotic species.
In mammals, the central component of the pathway is a large protein
kinase called mTOR that is the target of rapamycin, an FDA-approved
immunosuppressive drug that is also in clinical trials as an anti-cancer
agent and as a blocker of restenosis after balloon angioplasty.
In
addition to our work on growth control, we are developing and applying
new technologies that facilitate the analysis of gene function in
mammalian cells. We have developed ‘cell-based microarrays’
that allow us to look at the cellular effects of perturbing the
activity of thousands of genes in parallel. On a standard microscope
slide, we create microarrays consisting of 4,000-10,000 spots. Each
spot is composed of a cluster of live mammalian cells over- or under-expressing
a specific gene. The microarrays can be used to rapidly identify
genes that underlie cellular phenomena of interest.
|